New drug target for triple-negative breast cancer
Research reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically.
Read Original Article: New drug target for triple-negative breast cancer »
